Australia's Prescient Therapeutics jumps on collaboration with US-based cancer centre

Prescient Therapeutics

07/09/2022 02:25

** Shares of Australia's Prescient Therapeutics Ltd  PTX.AX 
rise as much as 5.6% to A$0.190, their highest since Aug. 26
    ** Clinical-stage oncology co announces collaboration with
MD Anderson Cancer Center, the largest cancer centre in the
United States  urn:newsml:reuters.com:*:nASX6QfNTj
    ** Says strategic collaboration to create adaptable CAR-T
cell therapies to treat haematological malignancies 
    ** stock up for a second straight session; down 27.8% this
year, as of last close

 (Reporting by Rishav Chatterjee in Bengaluru)
 ((Rishav.Chatterjee@thomsonreuters.com;))